Filing Details
- Accession Number:
- 0001415889-23-001734
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-01 16:30:17
- Reporting Period:
- 2023-01-30
- Accepted Time:
- 2023-02-01 16:30:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Transaction Summary
| Sold: | 16,000 shares | Avg. Price: $260.76 | Total Value: $4,172,125.69 |
| Number of Shares After Transactions: | 130 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-30 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 2,380 | $258.93 | 5,750 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-30 | 3,701 | $259.71 | 2,049 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-30 | 794 | $260.68 | 1,255 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-30 | 105 | $261.61 | 1,150 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-30 | 1,020 | $262.94 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-31 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-31 | 1,361 | $260.36 | 6,769 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-31 | 3,351 | $261.14 | 3,418 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-31 | 2,525 | $262.11 | 893 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-31 | 763 | $263.15 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2023-01-30 | 8,000 | $0.00 | 8,000 | $113.08 |
| Common Stock | Stock Options | Disposition | 2023-01-31 | 8,000 | $0.00 | 8,000 | $113.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 512,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
| 504,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $258.265 to $259.235. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $259.27 to $260.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $260.27 to $261.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $261.505 to $261.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $262.61 to $263.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $259.62 to $260.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $260.62 to $261.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $261.65 to $262.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $262.92 to $263.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
